Electrophysiology Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Electrophysiology Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Electrophysiology Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Electrophysiology Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Electrophysiology equipment analyzes the electrical activity of the heart. The equipment is used with cardiac catheters and sophisticated computers to generate electrocardiogram (EKG) tracings and electrical measurements with exquisite precision from within the heart chambers.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Electrophysiology Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electrophysiology Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrophysiology Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Electrophysiology Devices Overview
4 Products under Development
4.1 Electrophysiology Devices - Pipeline Products by Stage of Development
4.2 Electrophysiology Devices - Pipeline Products by Segment
4.3 Electrophysiology Devices - Pipeline Products by Territory
4.4 Electrophysiology Devices - Pipeline Products by Regulatory Path
4.5 Electrophysiology Devices - Pipeline Products by Estimated Approval Date
4.6 Electrophysiology Devices - Ongoing Clinical Trials
5 Electrophysiology Devices - Pipeline Products under Development by Companies
5.1 Electrophysiology Devices Companies - Pipeline Products by Stage of Development
5.2 Electrophysiology Devices – Companies Pipeline Products by Stage of Development
6 Electrophysiology Devices Companies and Product Overview
6.1 Ablacon Inc Company Overview
6.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 AccuPulse Medical Technology Co Ltd Company Overview
6.2.1 AccuPulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.3 Acotec Scientific Co Ltd Company Overview
6.3.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.4 Acutus Medical Inc Company Overview
6.4.1 Acutus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.5 Apama Medical Inc Company Overview
6.5.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.6 APT Medical Inc Company Overview
6.6.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.7 AtriCure Inc Company Overview
6.7.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
6.8 Aust Development, LLC Company Overview
6.8.1 Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview
6.9 Baylor College of Medicine Company Overview
6.9.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
6.1 Ben-Gurion University of the Negev Company Overview
6.10.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
6.11 Berlin Heals GmbH Company Overview
6.11.1 Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.12 Biosense Webster Inc Company Overview
6.12.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
6.13 BioSig Technologies Inc Company Overview
6.13.1 BioSig Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.14 BioTex Inc Company Overview
6.14.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
6.15 Biotronik AG Company Overview
6.15.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
6.16 Biotronik Australia Pty Ltd Company Overview
6.16.1 Biotronik Australia Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.17 Biotronik SE & Co KG Company Overview
6.17.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
6.18 Boston Scientific Corp Company Overview
6.18.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
6.19 Cardima, Inc. (Inactive) Company Overview
6.19.1 Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.2 CardioFocus Inc Company Overview
6.20.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
6.21 CardioNova Ltd Company Overview
6.21.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.22 CathEffects LLC Company Overview
6.22.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview
6.23 catheter precision Inc Company Overview
6.23.1 catheter precision Inc Pipeline Products & Ongoing Clinical Trials Overview
6.24 CathRx Ltd Company Overview
6.24.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.25 CathVision Aps Company Overview
6.25.1 CathVision Aps Pipeline Products & Ongoing Clinical Trials Overview
6.26 Cibiem, Inc. Company Overview
6.26.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.27 ClearPoint Neuro Inc Company Overview
6.27.1 ClearPoint Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview
6.28 Columbia University Company Overview
6.28.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
6.29 Conavi Medical Inc Company Overview
6.29.1 Conavi Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.3 Cordis Corp Company Overview
6.30.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
6.31 CoreMap Inc Company Overview
6.31.1 CoreMap Inc Pipeline Products & Ongoing Clinical Trials Overview
6.32 CoRepair, Inc Company Overview
6.32.1 CoRepair, Inc Pipeline Products & Ongoing Clinical Trials Overview
6.33 Corify Care SL Company Overview
6.33.1 Corify Care SL Pipeline Products & Ongoing Clinical Trials Overview
6.34 CryoTherapeutics Gmbh Company Overview
6.34.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview
6.35 CyberHeart Inc Company Overview
6.35.1 CyberHeart Inc Pipeline Products & Ongoing Clinical Trials Overview
6.36 EPD Solutions Ltd Company Overview
6.36.1 EPD Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.37 Epicardial Technologies Inc (Inactive) Company Overview
6.37.1 Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.38 EPMap-System GmbH & Co KG Company Overview
6.38.1 EPMap-System GmbH & Co KG Pipeline Products & Ongoing Clinical Trials Overview
6.39 Ethicon US LLC Company Overview
6.39.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
6.4 Eximo Medical Ltd Company Overview
6.40.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.41 Farapulse Inc Company Overview
6.41.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview
6.42 FocusStart LLC Company Overview
6.42.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
6.43 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview
6.43.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview
6.44 Galvanize Therapeutics Inc Company Overview
6.44.1 Galvanize Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.45 Hansen Medical Inc (Inactive) Company Overview
6.45.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.46 Hyblate Medical Company Overview
6.46.1 Hyblate Medical Pipeline Products & Ongoing Clinical Trials Overview
6.47 Imricor Medical Systems Inc Company Overview
6.47.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
6.48 Interventional Imaging, Inc. Company Overview
6.48.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.49 Iowa Approach Inc. Company Overview
6.49.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.5 Japan Lifeline Co Ltd Company Overview
6.50.1 Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.51 Jiangsu Tingsheng Technology Co Ltd Company Overview
6.51.1 Jiangsu Tingsheng Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.52 Johns Hopkins University Company Overview
6.52.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
6.53 King's College London Company Overview
6.53.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview
6.54 Koninklijke Philips NV Company Overview
6.54.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview
6.55 Lepu Medical Technology (Beijing) Co Ltd Company Overview
6.55.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.56 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview
6.56.1 Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.57 Maestro Heart SA Company Overview
6.57.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview
6.58 MC10 Inc Company Overview
6.58.1 MC10 Inc Pipeline Products & Ongoing Clinical Trials Overview
6.59 Medlumics SL Company Overview
6.59.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview
6.6 Medtronic Plc Company Overview
6.60.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
6.61 MedWaves Inc Company Overview
6.61.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview
6.62 Medyria AG Company Overview
6.62.1 Medyria AG Pipeline Products & Ongoing Clinical Trials Overview
6.63 MicroPort NeuroTech Ltd Company Overview
6.63.1 MicroPort NeuroTech Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.64 MicroPort Scientific Corp Company Overview
6.64.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
6.65 NeuTrace Inc Company Overview
6.65.1 NeuTrace Inc Pipeline Products & Ongoing Clinical Trials Overview
6.66 Northwestern University Company Overview
6.66.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
6.67 Novasentis Inc Company Overview
6.67.1 Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview
6.68 OrbusNeich Company Overview
6.68.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
6.69 Philips Healthcare Company Overview
6.69.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
6.7 S4 Medical Corp Company Overview
6.70.1 S4 Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
6.71 SCR, Inc. Company Overview
6.71.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.72 Seattle Children's Hospital Company Overview
6.72.1 Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
6.73 Seoul National University Hospital Company Overview
6.73.1 Seoul National University Hospital Pipeline Products & Ongoing Clinical Trials Overview
6.74 Shanghai HeartCare Medical Technology Co Ltd Company Overview
6.74.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.75 Shanghai MicroPort EP MedTech Co Ltd Company Overview
6.75.1 Shanghai MicroPort EP MedTech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.76 ST Cardio Technologies LLC Company Overview
6.76.1 ST Cardio Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
6.77 St. Jude Medical LLC Company Overview
6.77.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
6.78 Stanford University Company Overview
6.78.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
6.79 Stereotaxis Inc Company Overview
6.79.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview
6.8 Suzhou Aikemai Medical Technology Co Ltd Company Overview
6.80.1 Suzhou Aikemai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.81 Suzhou Bingjing Intelligent Medical Technology Co Ltd Company Overview
6.81.1 Suzhou Bingjing Intelligent Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.82 Suzhou Hengruihongyuan Medical Technology Co Ltd Company Overview
6.82.1 Suzhou Hengruihongyuan Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.83 Suzhou Xinmai Medical Equipment Co Ltd Company Overview
6.83.1 Suzhou Xinmai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.84 The Cleveland Clinic Foundation Company Overview
6.84.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview
6.85 University of Arkansas at Little Rock Company Overview
6.85.1 University of Arkansas at Little Rock Pipeline Products & Ongoing Clinical Trials Overview
6.86 University of Auckland Company Overview
6.86.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview
6.87 University of Maryland Company Overview
6.87.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview
6.88 University of Michigan Company Overview
6.88.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
6.89 University of Rochester Company Overview
6.89.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
6.9 University of Texas Medical Branch at Galveston Company Overview
6.90.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
6.91 University of Utah Company Overview
6.91.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
6.92 Vanderbilt University Company Overview
6.92.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
6.93 Vimecon GmbH Company Overview
6.93.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.94 Viscardia Inc Company Overview
6.94.1 Viscardia Inc Pipeline Products & Ongoing Clinical Trials Overview
6.95 Vivonics Inc Company Overview
6.95.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.96 Voyage Medical (Inactive) Company Overview
6.96.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.97 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
6.97.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
7 Electrophysiology Devices- Recent Developments
7.1 Apr 12, 2023: Medtronic has a layoff in California
7.2 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
7.3 Mar 30, 2023: Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023
7.4 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
7.5 Mar 02, 2023: Researchers suggest novel cutpoints for diagnosing cardiac hypertrophy in adolescents and young adults
7.6 Feb 23, 2023: Us2.ai to deliver AI-enabled echocardiography decision support to Brigham and Women’s Hospital’s Cardiac Imaging Core Laboratory
7.7 Feb 16, 2023: Integer Holdings Reports Results for Fourth Quarter and Full Year 2022
7.8 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
7.9 Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022
7.1 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
7.11 Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023
7.12 Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook
7.13 Jan 05, 2023: GE HealthCare appoints former Amazon exec as first chief technology officer
7.14 Dec 20, 2022: AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference
7.15 Nov 23, 2022: Medtronic Reports Quarterly Earnings
7.16 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
7.17 Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip's new CEO
7.18 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
7.19 Nov 07, 2022: OxSonics Therapeutics announces Jerome Marzinski Appointed as Chief Executive Officer
7.2 Nov 07, 2022: National study suggests it’s time to rethink how we treat atrial fibrillation
7.21 Oct 27, 2022: Integer Holdings Reports Third Quarter 2022 Results
7.22 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
7.23 Oct 11, 2022: AtriCure to Announce Third Quarter 2022 Financial Results
7.24 Sep 30, 2022: Natalie Caine named chief administrative officer at Mayo Clinic in Rochester
7.25 Sep 27, 2022: Catheter Precision names Fatih Ayoglu as Business Development Manager—EMEA
7.26 Sep 23, 2022: Mentice receives an order of USD 620,000 for simulation solutions and development services
7.27 Sep 07, 2022: Medtronic to appear at September investor conferences
7.28 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
7.29 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
7.3 Aug 16, 2022: AtriCure to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
7.31 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
7.32 Aug 08, 2022: ClearPoint Neuro Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs
7.33 Aug 03, 2022: Harvard Bioscience Announces Second Quarter 2022 Financial Results
7.34 Aug 02, 2022: AtriCure Reports Second Quarter 2022 Financial Results
7.35 Jul 28, 2022: Integer Holdings Reports Second Quarter 2022 Results
7.36 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022
7.37 Jul 20, 2022: AtriCure to Participate at Upcoming Investor Conferences
7.38 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
7.39 Jul 12, 2022: AtriCure to Announce Second Quarter 2022 Financial Results
7.4 Jul 08, 2022: Cordis Names Bryan Loo President of Asia-pacific Region
7.41 Jun 28, 2022: Japan Lifeline Co. Notice of Resolution of the 42nd Annual General Meeting of Shareholders
7.42 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
7.43 Jun 23, 2022: Cleveland Clinic Appoints Alex A. Adjei, M.D., Ph.D., as Chair of Taussig Cancer Institute
7.44 Jun 01, 2022: AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer
7.45 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
7.46 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
7.47 May 10, 2022: Stereotaxis Reports 2022 First Quarter Financial Results
7.48 May 04, 2022: Harvard Bioscience Announces First Quarter 2022 Financial Results
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Electrophysiology Devices - Pipeline Products by Stage of Development
Table 2: Electrophysiology Devices - Pipeline Products by Segment
Table 3: Electrophysiology Devices - Pipeline Products by Territory
Table 4: Electrophysiology Devices - Pipeline Products by Regulatory Path
Table 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date
Table 6: Electrophysiology Devices - Ongoing Clinical Trials
Table 7: Electrophysiology Devices Companies - Pipeline Products by Stage of Development
Table 8: Electrophysiology Devices – Companies Pipeline Products by Stage of Development
Table 9: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Ablamap System - Product Status
Table 11: Ablamap System - Product Description
Table 12: Ablasense - Product Status
Table 13: Ablasense - Product Description
Table 14: Ablacon Inc - Ongoing Clinical Trials Overview
Table 15: Ablamap System - A Randomized Controlled Study to Evaluate the Reliability of the Ablacon Electrographic FLOW (EGF) Algorithm Technology (Ablamap Software) to Identify AF Sources and Guide Ablation Therapy in Patients with Persistent Atrial Fibrillation
Table 16: AccuPulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 17: D Cardiac Electroanatomic Mapping System - Product Status
Table 18: D Cardiac Electroanatomic Mapping System - Product Description
Table 19: Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 20: ERA-C30 Endovenous Radiofrequency Closure Catheter - Product Status
Table 21: ERA-C30 Endovenous Radiofrequency Closure Catheter - Product Description
Table 22: ERA-C70 Endovenous Radiofrequency Closure Catheter - Product Status
Table 23: ERA-C70 Endovenous Radiofrequency Closure Catheter - Product Description
Table 24: ERA-G5 Endovenous Radiofrequency Closure Generator - Product Status
Table 25: ERA-G5 Endovenous Radiofrequency Closure Generator - Product Description
Table 26: Acutus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: AcQBlate Force Sensing Ablation System - Product Status
Table 28: AcQBlate Force Sensing Ablation System - Product Description
Table 29: AcQMap 3.0 Contact Mapping Catheter - Product Status
Table 30: AcQMap 3.0 Contact Mapping Catheter - Product Description
Table 31: VT Mapping Catheter - Product Status
Table 32: VT Mapping Catheter - Product Description
Table 33: Acutus Medical Inc - Ongoing Clinical Trials Overview
Table 34: AcQBlate Force Sensing Ablation System - Acqblate Force Sensing Ablation System EU Study for Atrial Fibrillation (AcQForce AF-EU)
Table 35: AcQBlate Force Sensing Ablation System - AcQBlate Force Sensing Ablation System US IDE Study for Atrial Fibrillation (AcQForce AF)
Table 36: Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: LUMINIZE Radiofrequency (RF) Balloon Catheter - Product Status
Table 38: LUMINIZE Radiofrequency (RF) Balloon Catheter - Product Description
Table 39: APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: D Cardiac Electrophysiological Mapping System - Product Status
Table 41: D Cardiac Electrophysiological Mapping System - Product Description
Table 42: High Integration Electrophysiological Recording System - Product Status
Table 43: High Integration Electrophysiological Recording System - Product Description
Table 44: Magnetic Positioning Pressure Sensing Radiofrequency Ablation Catheter - Product Status
Table 45: Magnetic Positioning Pressure Sensing Radiofrequency Ablation Catheter - Product Description
Table 46: Magnetoelectric Positioning High-density Mapping Catheter - Product Status
Table 47: Magnetoelectric Positioning High-density Mapping Catheter - Product Description
Table 48: Magnetoelectric Positioning Ring Mapping Catheter - Product Status
Table 49: Magnetoelectric Positioning Ring Mapping Catheter - Product Description
Table 50: Pressure Sensing Ablation Catheter - Product Status
Table 51: Pressure Sensing Ablation Catheter - Product Description
Table 52: Pressure Sensing Pulse Cancellation Fusion Catheter - Product Status
Table 53: Pressure Sensing Pulse Cancellation Fusion Catheter - Product Description
Table 54: RF Ablation Device with Pressure Sensing - Product Status
Table 55: RF Ablation Device with Pressure Sensing - Product Description
Table 56: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Next Generation RF Generator - Product Status
Table 58: Next Generation RF Generator - Product Description
Table 59: Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Endovascular Cardiac Optical Mapping Device - Product Status
Table 61: Endovascular Cardiac Optical Mapping Device - Product Description
Table 62: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Catheter-Based Electrophysiological Imaging System - Product Status
Table 64: Catheter-Based Electrophysiological Imaging System - Product Description
Table 65: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
Table 66: Excitation Wave Cancellation Device - Product Status
Table 67: Excitation Wave Cancellation Device - Product Description
Table 68: Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 69: C-MIC Device - Product Status
Table 70: C-MIC Device - Product Description
Table 71: Berlin Heals GmbH - Ongoing Clinical Trials Overview
Table 72: C-MIC Device - Early Feasibility Study of C-MIC Heart Failure Device
Table 73: C-MIC Device - Prospective, Randomized, Open, Comparison Study to Demonstrate the Performance and the Safety of Cardiac Microcurrent Therapy (C-MIC) System
Table 74: C-MIC Device - The C-MIC-II Follow-Up Study
Table 75: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 76: CARTO 4 - Product Status
Table 77: CARTO 4 - Product Description
Table 78: CARTO SMARTTOUCH 5D Catheter - Product Status
Table 79: CARTO SMARTTOUCH 5D Catheter - Product Description
Table 80: Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter - Product Status
Table 81: Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter - Product Description
Table 82: Navigation Guided Deflectable Sheath - Product Status
Table 83: Navigation Guided Deflectable Sheath - Product Description
Table 84: THERMOCOOL SMARTTOUCH SF-5D Catheter - Product Status
Table 85: THERMOCOOL SMARTTOUCH SF-5D Catheter - Product Description
Table 86: TRUPULSE Generator - Product Status
Table 87: TRUPULSE Generator - Product Description
Table 88: Biosense Webster Inc - Ongoing Clinical Trials Overview
Table 89: Heliostar Multi-Electrode Radiofrequency Balloon Ablation Catheter - Implementation of the HELIOSTAR in Real-world Clinical Practice at a High-volume Center - Operator Learning Curve and Procedural Outcome Parameters
Table 90: CARTO SMARTTOUCH 5D Catheter - Ground-Breaking Electroporation-based Intervention for PERSistent Atrial Fibrillation Treatment (BEAT PERS-AF)
Table 91: THERMOCOOL SMARTTOUCH SF-5D Catheter - Evaluation of the Safety and Performance of the Very High Power-short Duration QDOT Strategy in Patients Referred for Atrial Fibrillation Ablation
Table 92: TRUPULSE Generator - Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE)
Table 93: TRUPULSE Generator - Pulsed Field Ablation (PFA) System for the Treatment of Paroxysmal Atrial Fibrillation (PAF) by Irreversible Electroporation (IRE)
Table 94: TRUPULSE Generator - Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH SF Catheter With the TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)
Table 95: BioSig Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 96: PURE EP System - Product Status
Table 97: PURE EP System - Product Description
Table 98: PURE EP Version 2.0 - Product Status
Table 99: PURE EP Version 2.0 - Product Description
Table 100: PURE EP Version 3.0 - Product Status
Table 101: PURE EP Version 3.0 - Product Description
Table 102: BioSig Technologies Inc - Ongoing Clinical Trials Overview
Table 103: PURE EP System - To Assess the Efficacy Rate of Unipolar Polarity Switch for Lesion Assessment in Pulmonary Vein Isolation
Table 104: PURE EP System - To Assess the Predictive Value of High Frequency Algorithm of PURE EP for Low Amplitude Signal Detection
Table 105: PURE EP System - Validation of Safety and efficacy of the PURE EP System During Mapping and Ablation Procedures in Cardiac EP lab
Table 106: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 107: Cooled Tip Catheter - Product Status
Table 108: Cooled Tip Catheter - Product Description
Table 109: Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
Table 110: Amvia Edge - Product Status
Table 111: Amvia Edge - Product Description
Table 112: Amvia Sky - Product Status
Table 113: Amvia Sky - Product Description
Table 114: Truvia - Product Status
Table 115: Truvia - Product Description
Table 116: Biotronik AG - Ongoing Clinical Trials Overview
Table 117: Amvia Sky - BIO|CONCEPT.Amvia, First in Human Study for the Amvia/Solvia Pacemaker Family
Table 118: Biotronik Australia Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 119: ElePulse System - Product Status
Table 120: ElePulse System - Product Description
Table 121: Biotronik Australia Pty Ltd - Ongoing Clinical Trials Overview
Table 122: ElePulse System - Rapid One-Shot Electroporation Trial For Atrial Fibrillation: Reset-AF: Investigating the Effect of A Novel Intervention on Atrial Fibrillation Recurrence
Table 123: Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 7
Table 124: SentiCath - Product Status 7
Table 125: SentiCath - Product Description 7
Table 126: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 127: Intellagen - Product Status
Table 128: Intellagen - Product Description
Table 129: Intellanav Stablepoint - Product Status
Table 130: Intellanav Stablepoint - Product Description
Table 131: LabSystem Pro NextGen - Product Status
Table 132: LabSystem Pro NextGen - Product Description
Table 133: Lesion Assessment Device - Product Status
Table 134: Lesion Assessment Device - Product Description
Table 135: Next Generation Blazer Catheter - Product Status
Table 136: Next Generation Blazer Catheter - Product Description
Table 137: Next Generation IntellaTip Catheter - Product Status
Table 138: Next Generation IntellaTip Catheter - Product Description
Table 139: OI System - Product Status
Table 140: OI System - Product Description
Table 141: POLARx Next Generation Catheter - Product Status
Table 142: POLARx Next Generation Catheter - Product Description
Table 143: POLARx Single Shot Cryoballoon - Product Status
Table 144: POLARx Single Shot Cryoballoon - Product Description
Table 145: Rhythmia 5.0 - Product Status
Table 146: Rhythmia 5.0 - Product Description
Table 147: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 148: Intellanav Stablepoint - Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation
Table 149: POLARx Single Shot Cryoballoon - Comparison of the PolarX and the Arctic Front Cryoballoon for Pulmonary Vein

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings